Stay updated on Obeldesivir Study in High-risk COVID-19: Clinical Trial

Sign up to get notified when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Obeldesivir Study in High-risk COVID-19: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T17:12:48.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The clinical study results for obeldesivir (GS-5245) have been posted, detailing its efficacy and safety in treating COVID-19, including various hospitalization and adverse event metrics, while previous results and definitions have been removed.
    Difference
    33%
    Check dated 2024-12-21T20:29:06.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T12:18:17.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    3%
    Check dated 2024-12-07T10:25:13.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Several key resources and links related to clinical trials and COVID-19 information have been removed, which may impact access to important study data and updates.
    Difference
    4%
    Check dated 2024-11-23T03:51:06.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new resources including links to MedlinePlus and Gilead clinical trials, as well as new data fields for study information.
    Difference
    5%
    Check dated 2024-11-15T22:11:15.000Z thumbnail image

Stay in the know with updates to Obeldesivir Study in High-risk COVID-19: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.